Zaccaria Affif, Roux-Dalvai Florence, Bouamrani Ali, Mombrun Adrien, Mossuz Pascal, Monsarrat Bernard, Berger François
Clinatec CEA-LETI, Grenoble, France.
CNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France ; Université de Toulouse, UPS, IPBS, Toulouse, France.
Int J Nanomedicine. 2015 Mar 9;10:1869-83. doi: 10.2147/IJN.S70503. eCollection 2015.
Nanoparticle (NP)-protein interactions in complex samples have not yet been clearly understood. Nevertheless, several studies demonstrated that NP's physicochemical features significantly impact on the protein corona composition. Taking advantage of the NP potential to harvest different subsets of proteins, we assessed for the first time the capacity of three kinds of superparamagnetic NPs to highlight the erythrocyte minor proteome. Using both qualitative and quantitative proteomics approaches, nano-liquid chromatography-tandem mass spectrometry allowed the identification of 893 different proteins, confirming the reproducible capacity of NPs to increase the number of identified proteins, through a reduction of the sample concentration range and the capture of specific proteins on the three different surfaces. These NP-specific protein signatures revealed significant differences in their isoelectric point and molecular weight. Moreover, this NP strategy offered a deeper access to the erythrocyte proteome highlighting several signaling pathways implicated in important erythrocyte functions. The automated potentiality, the reproducibility, and the low-consuming sample demonstrate the strong compatibility of our strategy for large-scale clinical studies and may become a standardized sample preparation in future erythrocyte-associated proteomics studies.
复杂样品中纳米颗粒(NP)与蛋白质的相互作用尚未完全明晰。然而,多项研究表明,NP的物理化学特性对蛋白质冠层组成有显著影响。利用NP捕获不同蛋白质亚群的潜力,我们首次评估了三种超顺磁性NP突显红细胞微量蛋白质组的能力。通过定性和定量蛋白质组学方法,纳米液相色谱-串联质谱鉴定出893种不同蛋白质,证实了NP通过缩小样品浓度范围和在三种不同表面捕获特定蛋白质来增加已鉴定蛋白质数量的可重复性能力。这些NP特异性蛋白质特征在等电点和分子量上显示出显著差异。此外,这种NP策略为深入了解红细胞蛋白质组提供了途径,突显了与重要红细胞功能相关的多种信号通路。该方法的自动化潜力、可重复性和低样品消耗表明我们的策略与大规模临床研究具有很强的兼容性,可能成为未来红细胞相关蛋白质组学研究中的标准化样品制备方法。